logo

Middle East and North Africa Region

HPV Regional Profile

News

Announcing our Interactive Map in the MENA Region

We have crafted a new interactive map to support the efforts of the public health community to drive evidence-based public health policy and advocacy. The map will come handy if you want to explore the latest data on burden of HPV incidence and mortality in the MENA region.

Explore the interactive map
Statistics and Data Analytics
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

11202

cases in 2018

DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

7601

deaths in 2018

Status of National HPV Vaccination Programme

Libya and the UAE are the only countries in the region that have the HPV vaccine in their national immunization programs.

Description
HPV

General Information

Human Papillomavirus

Burden of HPV infection

Across countries in the Middle East and North Africa (MENA) region (as defined by UNAIDS), between 0.2% and 13.9% of people are estimated to have HPV, which causes approximately 70% of invasive cervical cancers.1

Link between HPV infection and cancer

Human papillomavirus (HPV), which is sexually transmitted, is the most common viral infection of the reproductive tract. Most sexually active women and men will be infected at some point in their lives and some may be repeatedly infected.

There are many types of HPV, and many do not cause problems. However, certain types of HPV can persist and progress to cancer. Cervical cancer is by far the most common HPV-related disease. Nearly all cases of cervical cancer can be attributable to HPV infection.4

Burden of cervical cancer

Cervical cancer causes at least 7,601 deaths among women annually in the MENA region (as defined by UNAIDS). Between 2012 and 2018, the number of deaths every year due to cervical cancer doubled in most countries in the region.1,2 If decisive action is not taken at the national and regional levels, annual deaths due to the preventable disease will double again by 2040, reaching 15,728 deaths per year.3 In the region, at least 11,202 women are newly diagnosed with cervical cancer each year.

Across the MENA region, incidence and mortality rates vary. For example, Somalia and Morocco have the highest incidence and mortality rates, with 24.0 and 17.2 women per 100,000 being newly diagnosed with cervical cancer annually and at least 21.9 and 12.6 women per 100,000 dying due to cervical cancer per year, respectively. Whereas Iran, Iraq and Yemen have the lowest (around 2 per 100,000 women are diagnosed per year and about 1 per 100,000 die because of cervical cancer annually).2


Cervical cancer incidence and mortality rate projections
Country Profiles

Algeria


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

1594


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

1066


Read more

Jordan


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

104


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

61


Read more

Kuwait


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

59


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

59


Read more

Lebanon


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

192


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

125


Read more

Libya


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

319


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

127


Read more

Morocco


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

3388


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

2465


Read more

Qatar


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

19


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

12


Read more

Saudi Arabia


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

316


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

158


Read more

The United Arab Emirates


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

108


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

56


Read more

Tunisia


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

285


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

199


Read more

Turkey


NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)

2356


DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)

1280


Read more
Research and Publications
  1. Özdemir, Serpil, et al. “Analysis of Community-Based Researches Related to Knowledge, Awareness, Attitude and Behaviors towards HPV and HPV Vaccine Published in Turkey: A Systematic Review.” Journal of the Turkish German Gynecological Association, Aug. 2019, doi:10.4274/jtgga.galenos.2019.2019.0071.
  2. Chantziantoniou, Nikolaos. “Impediments to the Historical Development of the Clinical Pap Test in the United States: Their Relevance in Optimizing Cervical Cancer Screening in the State of Qatar.” Theses & Dissertations, Aug. 2019, https://digitalcommons.unmc.edu/etd/391.
  3. Sallam, Malik, et al. “Dental Students’ Awareness and Attitudes toward HPV-Related Oral Cancer: A Cross Sectional Study at the University of Jordan.” BMC Oral Health, vol. 19, no. 1, Aug. 2019, p. 171, doi:10.1186/s12903-019-0864-8.
  4. Ali, Mohamed A. M., et al. “Cervical High-Risk Human Papillomavirus Infection among Women Residing in the Gulf Cooperation Council Countries: Prevalence, Type-Specific Distribution, and Correlation with Cervical Cytology.” Cancer Cytopathology, vol. 0, no. 0, Aug. 2019, doi:10.1002/cncy.22165.
  5. Fani, Mona, et al. “Correlation of Human Papillomavirus 16 and 18 with Cervical Cancer and Their Diagnosis Methods in Iranian Women: A Systematic Review and Meta-Analysis.” Current Problems in Cancer, July 2019, doi:10.1016/j.currproblcancer.2019.06.008.
  6. Maatouk, Ismael, and Rusi Jaspal. “P253 HPV Vaccine Knowledge and Acceptability among MSM in Lebanon: A Qualitative Study.” Sexually Transmitted Infections, vol. 95, no. Suppl 1, July 2019, pp. A152–53, doi:10.1136/sextrans-2019-sti.386.
  7. Mohammadpour, Bashir, et al. “Prevalence and Association of Human Papillomavirus with Esophageal Squamous Cell Carcinoma in Iran: A Systematic Re-View and Meta-Analysis.” Iranian Journal of Public Health, vol. 48, no. 7, July 2019, pp. 1215–26, http://ijph.tums.ac.ir/index.php/ijph/article/view/17580.
  8. Aynaci, Gulden, and Zuhal Gusku. “Awareness of HPV and HPV Vaccination in Undergraduate Students in the North West Region of Turkey: Near Future Outlook.” The Journal of Infection in Developing Countries, vol. 13, no. 06, June 2019, pp. 516–25, doi:10.3855/jidc.11405.
  9. AlMansoori, Latifa Sarhan, et al. “Physicians’ Knowledge, Attitude, and Practices toward HPV Disease and Vaccination in Al Ain City, UAE.” International Journal of Contemporary Research and Review, vol. 10, no. 06, June 2019, pp. 20741–50, doi:10.15520/ijcrr.v10i06.706.
  10. Gultekin, Murat, et al. “Mega Hpv Laboratories for Cervical Cancer Control: Challenges and Recommendations from a Case Study of Turkey.” Papillomavirus Research, vol. 7, June 2019, pp. 118–22, doi:10.1016/j.pvr.2019.03.002.
  11. Almehmadi, Mazen, et al. “Awareness of Human Papillomavirus Infection Complications, Cervical Cancer, and Vaccine among the Saudi Population. A Cross-Sectional Survey.” Saudi Medical Journal, vol. 40, no. 6, June 2019, pp. 555–59, doi:10.15537/smj.2019.6.24208.
  12. Alsbeih, Ghazi, et al. “Prevalence of Human Papillomavirus (HPV) Infection and the Association with Survival in Saudi Patients with Head and Neck Squamous Cell Carcinoma.” Cancers, vol. 11, no. 6, June 2019, p. 820, doi:10.3390/cancers11060820.
  13. Kaddar, Miloud, et al. “Vaccine Procurement in the Middle East and North Africa Region: Challenges and Ways of Improving Program Efficiency and Fiscal Space.” Vaccine, May 2019, doi:10.1016/j.vaccine.2019.04.029.
  14. Babazadeh, Towhid, et al. “Predictors of Pap Smear Screening Behavior Among Rural Women in Tabriz, Iran: An Application of Health Belief Model.” International Journal of Cancer Management, vol. In Press, no. In Press, May 2019, doi:10.5812/ijcm.87246.
  15. Kilic, Ayse, et al. “Breast and Cervical Cancer Screening for Women with Physical Disabilities: A Qualitative Study of Experiences and Barriers.” Journal of Advanced Nursing, vol. 0, no. ja, May 2019, doi:10.1111/jan.14048.
View all publications
News
References
  1. Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Statistics. Retrieved December 19, 2018, from http://www.hpvcentre.net/datastatistics.php

  2. Cancer Today. (2018, September). Retrieved October 19, 2018, from https://gco.iarc.fr/.

  3. Cancer Tomorrow. (2018, September). Retrieved October 19, 2018, from https://gco.iarc.fr/.

  4. Human papillomavirus (HPV) and cervical cancer. (2018, February 15). Retrieved November 2, 2018, from http://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cance

Disclaimer
Please notify us if you know of other resources, including academic publications, news articles and information that should be added to this page by emailing: hpvmena@gmail.com.